|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 363.39 USD | -0.06% |
|
-2.88% | +11.02% |
| 07-08 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
| 07-08 | Morgan Stanley Adjusts Price Target Amgen to $333 From $340, Maintains Equalweight Rating | MT |
Chart calendar Amgen Inc.
Upcoming events on Amgen Inc.
No events available
Past events on Amgen Inc.
| 2026-05-19 | Présentation aux Actionnaires / Analystes | 14:00 |
| 2026-05-19 | Annual General Meeting | 14:00 |
| 2026-04-30 | Earnings presentation | 16:30 |
| 2026-04-30 | Earnings release - Q1 2026 | |
| 2026-02-03 | Earnings release - Q4 2025 | |
| 2026-02-03 | Earnings presentation | 16:30 |
| 2025-11-04 | Earnings presentation | 16:30 |
| 2025-11-04 | Earnings release - Q3 2025 | |
| 2025-08-05 | Earnings presentation | 16:30 |
| 2025-08-05 | Earnings release - Q2 2025 |
Past dividends on Amgen Inc.
| 2026-05-15 | Ex-dividend date - 2.52 USD | 00:00 |
| 2026-02-13 | Ex-dividend date - 2.52 USD | 00:00 |
| 2025-11-21 | Ex-dividend date - 2.38 USD | 00:00 |
| 2025-08-22 | Ex-dividend date - 2.38 USD | 00:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 28 190 28 108 0.29% | 33 424 33 188 0.71% | 36 751 36 337 1.14% | 37 763 | 38 690 | 39 730 |
|
EBITDA Million USD | Released Forecast Spread | 17 470 16 351 6.84% | 20 620 18 896 9.12% | 21 370 21 230 0.66% | 21 414 | 21 526 | 20 886 |
|
EBIT Million USD | Released Forecast Spread | 13 399 13 423 -0.18% | 15 028 14 802 1.52% | 16 203 15 817 2.44% | 16 502 | 17 001 | 17 490 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 7 855 8 859 -11.33% | 4 609 6 690 -31.1% | 8 976 8 281 8.39% | 9 309 | 10 353 | 10 973 |
|
Net income Million USD | Released Forecast Spread | 6 717 7 401 -9.24% | 4 090 4 987 -17.99% | 7 711 7 219 6.82% | 8 231 | 8 860 | 9 287 |
|
EPS USD | Released Forecast Spread | 12,5 13,8 -9.66% | 7,56 9,13 -17.21% | 14,2 12,9 10.57% | 15,3 | 16,7 | 17,3 |
| Announcement Date | 06/02/24 | 04/02/25 | 03/02/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 | 2028 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 8 503 8 499 0.05% | 9 086 8 869 2.44% | 8 149 8 035 1.42% | 9 179 8 917 2.94% | 9 557 8 966 6.59% | 9 866 9 460 4.29% | 8 618 8 571 0.55% | 9 422 | 9 693 | 9 978 | 8 792 | 9 546 | 9 782 | 10 177 | 8 888 |
|
EBITDA Million USD | Released Forecast Spread | 5 440 5 103 6.61% | 5 430 4 631 17.27% | 4 986 4 674 6.68% | 5 634 4 691 20.1% | 5 612 5 877 -4.52% | 5 138 6 955 -26.13% | 4 837 5 069 -4.58% | 5 377 | 5 549 | 5 558 | |||||
|
EBIT Million USD | Released Forecast Spread | 4 044 3 884 4.13% | 4 033 3 843 4.94% | 3 599 3 316 8.54% | 4 293 3 969 8.16% | 4 305 3 793 13.51% | 4 006 3 638 10.1% | 3 721 3 618 2.84% | 4 143 | 4 290 | 4 307 | 3 863 | 4 309 | 4 492 | 4 711 | 3 786 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 3 101 1 385 123.85% | 782 1 836 -57.41% | 1 973 1 108 78.07% | 1 568 | 3 921 1 134 245.77% | 1 514 1 546 -2.07% | 2 084 1 741 19.7% | 1 981 | 2 185 | 2 130 | |||||
|
Net income Million USD | Released Forecast Spread | 2 830 1 348 109.99% | 627 1 243 -49.54% | 1 730 1 053 64.24% | 1 432 1 561 -8.25% | 3 216 1 355 137.31% | 1 333 1 238 7.66% | 1 819 1 603 13.47% | 2 065 | 2 148 | 2 219 | 1 894 | 2 136 | 2 194 | 2 380 | |
|
EPS USD | Released Forecast Spread | 5,22 2,61 100.1% | 1,16 2,49 -53.42% | 3,20 1,89 69.58% | 2,65 3,12 -15.05% | 5,93 2,60 128.14% | 2,45 2,41 1.5% | 3,34 3,02 10.58% | 3,75 | 4,26 | 4,04 | 3,97 | 4,41 | 4,34 | 4,30 | |
| Announcement Date | 30/10/24 | 04/02/25 | 01/05/25 | 05/08/25 | 04/11/25 | 03/02/26 | 30/04/26 | - | - | - | - | - | - | - | - |
| Today |  | Ex-dividend date - 0.77711 EUR | 00:00 |
| 2026-07-14 | | Ex-dividend date - 0.052 CNY | 00:00 |
| 2026-07-15 | | Earnings release - Q2 2026 | 06:45 |
| 2026-07-15 | | Earnings presentation | 08:30 |
| 2026-07-15 | | Ex-dividend date - 1.73 USD | 00:00 |
| 2026-07-15 | | Earnings release - Q2 2026 | |
| 2026-07-15 | | Earnings presentation | 08:00 |
| 2026-07-15 | | Extraordinary General Meeting | 02:30 |
| 2026-07-15 | | Ex-dividend date - 0.05 CNY | 00:00 |
| 2026-07-15 | | Ex-dividend date - 0.2 CNY | 00:00 |
Past sector events for Amgen Inc.
| 2026-07-11 | | Board of Directors Meeting | 03:00 |
| 2026-07-10 | | Ex-dividend date - 8 INR | 00:00 |
| 2026-07-10 | | Extraordinary General Meeting | 02:00 |
| 2026-07-10 | | Extraordinary General Meeting | 02:00 |
| 2026-07-10 | | Ex-dividend date - 0.17248 HKD | 00:00 |
| 2026-07-10 | | Présentation aux Actionnaires / Analystes | 01:30 |
| 2026-07-10 | | Annual General Meeting | 01:30 |
| 2026-07-09 | | Information meeting | 07:00 |
| 2026-07-09 | | Earnings presentation | 02:00 |
| 2026-07-09 | | Ex-dividend date - 0.15 CNY | 00:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
- Calendar Amgen Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
